Completed PHASE1 INTERVENTIONAL NCT00081848

Vaccine Therapy and Radiation to Liver Metastasis in Patients With CEA-Positive Solid Tumors

A Pilot Trial of a CEA-TRICOM Based Vaccine and Radiation to Liver Metastasis in Adults With CEA Positive Solid Tumors

Sponsor: National Cancer Institute (NCI)

Interventions Celecoxib Recombinant Fowlpox-GM-CSF rF-CEA(6D)/TRICOM rV-CEA(6D)/TRICOM-rF-CEA(6D)/TRICOM

Updated 5 times since 2017 Last updated: Jun 30, 2017 Started: Apr 20, 2004 Primary completion: Aug 23, 2007 Completion: Aug 23, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00081848, this PHASE1 trial focuses on Liver Neoplasms and remains completed. Sponsored by National Cancer Institute (NCI), it has been updated 5 times since 2004, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Apr 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Cancer Institute (NCI)

Data source: National Institutes of Health Clinical Center (CC)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bethesda, United States